Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Parkinson's Disease |
Free Subscription
1 BMC Neurol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Parkinson's Disease is free of charge.
The Black and African American Connections to Parkinson's Disease (BLAAC PD)
study protocol.
BMC Neurol. 2024;24:403.
PubMed
Abstract available
Myocarditis on Clozapine 50 mg/d in a Patient With Parkinson's Disease.
J Clin Psychopharmacol. 2024 Oct 25. doi: 10.1097/JCP.0000000000001927.
PubMed
Behavioral disorders in Parkinson disease: current view.
J Neural Transm (Vienna). 2024 Oct 25. doi: 10.1007/s00702-024-02846.
PubMed
Abstract available
Grasping the big picture: impact analysis of screening tools for timely referral
for device-aided therapies.
J Neural Transm (Vienna). 2024;131:1295-1305.
PubMed
Abstract available
Monotherapy with infusion therapies - useful or not?
J Neural Transm (Vienna). 2024;131:1341-1348.
PubMed
Abstract available
The global dimension of Parkinson's disease genetics.
Lancet Neurol. 2024 Oct 21:S1474-4422(24)00435.
PubMed
Uncovering the genetic basis of Parkinson's disease globally: from discoveries to
the clinic.
Lancet Neurol. 2024 Oct 21:S1474-4422(24)00378.
PubMed
Abstract available
Prospective Connectomic-Based Deep Brain Stimulation Programming for Parkinson's
Disease.
Mov Disord. 2024 Oct 21. doi: 10.1002/mds.30026.
PubMed
Abstract available
Impaired Gait, Postural Instability, and Rigidity in Relation to CB1 Receptor
Availability in Parkinson's Disease.
Mov Disord. 2024 Oct 22. doi: 10.1002/mds.30042.
PubMed
Abstract available
alpha-Synuclein Pathology in the Carotid Body: Experimental Evidence for a possible
Contributor to Respiratory Impairment in Parkinson's Disease.
Mov Disord. 2024 Oct 24. doi: 10.1002/mds.30036.
PubMed
The Effect of Dysautonomia on Motor, Behavioral, and Cognitive Fluctuations in
Parkinson's Disease.
Mov Disord. 2024 Oct 25. doi: 10.1002/mds.30044.
PubMed
Abstract available
Parkinson's Disease. Reply.
N Engl J Med. 2024;391:1559.
PubMed
Parkinson's Disease.
N Engl J Med. 2024;391:1558-1559.
PubMed
Parkinson's Disease.
N Engl J Med. 2024;391:1558.
PubMed
Multiomics approach discloses lipids and metabolites profiles associated to
Parkinson's disease stages and applied therapies.
Neurobiol Dis. 2024 Oct 18:106698. doi: 10.1016/j.nbd.2024.106698.
PubMed
Abstract available
Low-beta versus high-beta band cortico-subcortical coherence in movement
inhibition and expectation.
Neurobiol Dis. 2024;201:106689.
PubMed
Abstract available
Author Response: Fine Particulate Matter and Parkinson Disease Risk Among
Medicare Beneficiaries.
Neurology. 2024;103:e210092.
PubMed
Functional neural substrates of Parkinson's disease and potential underpinnings
of acute responses to acupuncture stimulation.
Neuroscience. 2024 Oct 22:S0306-4522(24)00534.
PubMed
Abstract available
Investigating the effects of a daily multidisciplinary intensive outpatient
rehabilitation program on innovative biomarkers in people with Parkinson's
disease: Study protocol for a phase III randomized controlled clinical trial.
PLoS One. 2024;19:e0309405.
PubMed
Abstract available
Prescription trends in Japanese advanced Parkinson's disease patients with
non-motor symptoms: J-FIRST.
PLoS One. 2024;19:e0309297.
PubMed
Abstract available
Thank you for your interest in scientific medicine.